Our teams and partners advanced work on more than 40 R&D projects in 2020, including 22 clinical trials conducted across 83 sites in 28 countries. More than 3,000 patients – nearly half of them children – were actively enrolled in DNDi trials. We also mobilized our networks and applied our experience in needs-driven, non-profit R&D and access to COVID-19.